Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

Deepak L Bhatt, Marcus D Flather, Werner Hacke, Peter B Berger, Henry R Black, William E Boden, Patrice Cacoub, Eric A Cohen, Mark A Creager, J Donald Easton, Christian W Hamm, Graeme J Hankey, S Claiborne Johnston, Koon-Hou Mak, Jean-Louis Mas, Gilles Montalescot, Thomas A Pearson, P Gabriel Steg, Steven R Steinhubl, Michael A WeberLiz Fabry-Ribaudo, Tingfei Hu, Eric J Topol, Keith A A Fox, CHARISMA Investigators

Research output: Contribution to journalArticlepeer-review

747 Citations (Scopus)


The purpose of this study was to determine the possible benefit of dual antiplatelet therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic peripheral arterial disease (PAD).
Original languageEnglish
Pages (from-to)1982-8
Number of pages7
JournalJournal of the American College of Cardiology
Issue number19
Publication statusPublished - 15 May 2007


  • Aged
  • Aspirin
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Peripheral Vascular Diseases
  • Platelet Aggregation Inhibitors
  • Stroke
  • Ticlopidine
  • Treatment Outcome

Cite this